Tightly targeted cancer therapy receives marketing approval.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
DeCarvalho, S., Rand, H. J. & Lewis, A. Nature 202, 255-258 (1964).
Junutula, J. R. et al. Nature Biotechnol. 26, 925-932 (2008).
About this article
Cite this article
Ledford, H. Toxic antibodies blitz tumours. Nature (2011). https://doi.org/10.1038/476380a